Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 4,120.00
+95.00 (2.36%)
At close: Oct 13, 2026
Cellromax Science Revenue
Cellromax Science had revenue of 5.09B KRW in the quarter ending June 30, 2026, a decrease of -21.24%. This brings the company's revenue in the last twelve months to 19.60B, down -16.01% year-over-year. In the year 2025, Cellromax Science had annual revenue of 22.18B with 2.56% growth. That makes Cellromax Science the 35,488th largest company in the world by revenue and 2,262nd in South Korea.
Revenue (ttm)
19.60B
Revenue Growth
-16.01%
P/S Ratio
2.35
Revenue / Employee
455.91M
Employees
43
Market Cap
46.00B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.18B | 553.61M | 2.56% |
| Dec 31, 2024 | 21.63B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.